CCMB

CSIR - Centre for Cellular & Molecular Biology

The Innovation Engine of India

Coronavirus cell culture to make vaccines and test drugs at CCMB

Over the last month and a half, CSIR-Centre for Cellular and Molecular Biology (CCMB) has establishedstable cultures of COVID-19 causing coronavirus, SARS-CoV-2 from patients’ samples.A team of researchers led by the Virologist in CCMB, Dr. Krishnan H Harshan have isolated infectious viruses from several isolates. The ability to culture the virus in lab enables CCMB… Continue reading Coronavirus cell culture to make vaccines and test drugs at CCMB

Genetic study traced the source of extinct Indian cheetah

Over the last many centuries India kept losing cheetah, one of its big cats until just after independence. Today Africa harbours the highest number of these cats, called the African cheetah. The Asiatic cheetahs, on the other hand, are found in numbers as small as 50 in Iran. For more than a decade, India has… Continue reading Genetic study traced the source of extinct Indian cheetah

The genomic landscape of SARS-CoV-2 in India

Sept 20, 2020: Scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad have analysed more than 2000 SARS-CoV-2 genomes from India available in the public domain to understand the various strains in circulation. Earlier in June, the team had revealed the presence of a distinct virus population among Indians. This was named the… Continue reading The genomic landscape of SARS-CoV-2 in India

Partnering with Public – via CCMB’s Open Week

CSIR-Centre for Cellular and Molecular Biology (CCMB) opens up to public every year on 26th September on occasion of CSIR’s Foundation Day. But given the ongoing COVID-19 crisis, the CCMB festival has been restructured this year. Instead of a single day, the event will run onlineover a whole week, from Sept 21st to 26th, 2020… Continue reading Partnering with Public – via CCMB’s Open Week

CCMB scientist, R Sankaranarayanan wins the Infosys Prize 2020 in life sciences

Dr Rajan Sankaranarayanan, Chief Scientist at CSIR-Centre for Cellular and Molecular Biology (CCMB) has won the prestigious Infosys Prize 2020 for the life sciences category. Dr Sankaranarayanan is a structural biologist who studies structures of proteins in cells. He has made seminal contributions in on how accuracy is maintained by cellular machinery while building proteins… Continue reading CCMB scientist, R Sankaranarayanan wins the Infosys Prize 2020 in life sciences

New UKvariant in India, but the existing COVID-19 precautions should work fine against it

The new variant of the coronavirus SARS-CoV-2 that causes COVID-19, B.1.1.7 is believed to be 71% more transmittable than the other variants. First reported in the UK in September 2020, this variant makes up for 60% of all coronavirus infection there. Many countries including India have temporarily halted flights from the UK.By tracing and testing… Continue reading New UKvariant in India, but the existing COVID-19 precautions should work fine against it

Coronavirus can be transiently air-borne; but COVID-19 preventive measures can keep you safe

CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad and CSIR-Institute of Microbial Technology (IMTech), Chandigarh have released their data on the air-borne nature of coronavirus, SARS-CoV-2. Scientists have worked with hospitals, 3 in Hyderabad and 3 in Chandigarh to find if the virus particles can be found in air samples in the hospital wards. They… Continue reading Coronavirus can be transiently air-borne; but COVID-19 preventive measures can keep you safe

Analysis of SARS-CoV-2 viral variants in India

The first patient of COVID-19 in India was identified on 30th Jan 2020 in Kerala. Over the past year, the genome of the coronavirus SARS-CoV-2 has evolved as it transmits through its human hosts. Scientists from CSIR-CCMB have been at the forefront of sequencing and analyzing its genome in India. In a recent publication, they… Continue reading Analysis of SARS-CoV-2 viral variants in India

54% of Hyderabad’s population estimated to have antibodies against coronavirus

A joint effort by CSIR-Centre for Cellular and Molecular Biology (CCMB), ICMR-National Institute of Nutrition (NIN)and Bharat Biotech has estimated the seroprevalence of antibodies against the coronavirus SARS-CoV-2 in Hyderabad. This study of around9000 samples, finds that around 54% of Hyderabadis show antibodies against SARS-CoV-2, indicating prior exposure to the coronavirus. Scientists checked for antibodies… Continue reading 54% of Hyderabad’s population estimated to have antibodies against coronavirus

SpiceHealth signs MoU with CSIR-CCMB; will be the first to launch dry swab direct RT-PCR Covid-19 testing in India

The game changing technology of dry swab RNA-extraction free testing to be introduced across SpiceHealth mobile laboratories; will significantly ramp up testing, reduce cost & time • To use the dry swab method in RT-PCR testing mobile labs • 5 operational labs, conducting 10,000 tests per day • Follows the launchof the most affordable &… Continue reading SpiceHealth signs MoU with CSIR-CCMB; will be the first to launch dry swab direct RT-PCR Covid-19 testing in India

This will close in 0 seconds

Skip to content